CD274 and neoplasm: Particularly, significant increases in PD-L1, as well as in tumor-infiltrating immune cells, including CD4+, CD8+, ICOS+, CD45RO+, granzyme-B+, and CD68+ cells are detected in post-treatment tumors which were not seen in the control group treated with androgen deprivation therapy alone [410].